ClinicalTrials.gov record
Completed Phase 3 Interventional

Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)

ClinicalTrials.gov ID: NCT03310125

Public ClinicalTrials.gov record NCT03310125. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 9:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03310125
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Population Health Research Institute
Other
Enrollment
3,209 participants

Conditions and interventions

Interventions

  • Colchicine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 13, 2018
Primary completion
Jul 25, 2023
Completion
Jul 25, 2023
Last update posted
Aug 6, 2023

2018 – 2023

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Cleveland Clinic Florida Weston Florida 33331
Henry Ford Hospital Detroit Michigan 48202
Stony Brook University Hospital Stony Brook New York 11794
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157
Fairview Hospital Cleveland Ohio 44111
The Ohio State University Wexner Medical Center Columbus Ohio 43210
Rhode Island Hospital Providence Rhode Island 02903
The University of Texas MD Anderson Cancer Center Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03310125, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2023 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03310125 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →